Market Gems:Stocks w/Strong Earnings and High Tech. Rank Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: kha vu who wrote (76081)	12/21/1999 1:01:00 PM
From: Jenna	Read Replies (6) of 120523

ALLP nice chart formation, upgraded and now a buy before he H&Q healthcare conference. MEDX is also in a good position for being upgraded before the conference, in a good strong uptrend and good news. (ABGX just too expensive)Both companies genetically alter mice with disease to make immunizations against human disease. Since ABGX hs been around longer the price of its stock is higher, but MEDX should come around. ALXN news today and did well since its earnings came out. One of the few biotechs. I'm also interested in RZYM, SUPG, and UTHR. The conference will probably bring out the best like SEPR, VICL, CEGE, CHIR, AMGN and BGEN.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next